Digital drugs

Author: d | 2025-04-25

Digital Drugs’s tracks 808s by Digital Drugs published on TZ. Lost In by Digital Drugs published on TZ. SUMMER LOVE MIXTAPE by Digital Drugs published on TZ. Moon Visions 2:24 AM

Digital drugs? : r/Drugs - Reddit

Can how you perceive audio get you high? Last month, the academic journal Drug and Alcohol Review published a survey that proposed listeners have used audio files with binaural beats as "digital drugs" to try and experience intoxicating effects. And reporting around the study is suggesting it actually worked.A binaural beat is an auditory allusion one can achieve when different tones are played in each ear, as shown in a 2020 Science Daily study. That paper indicated binaural beats didn't affect mood.But the results published on March 30 in the new study from Australia's RMIT University, titled "Who Uses Digital Drugs? An International Survey of 'Binaural Beat' Consumers," show that respondents in the Global Drug Survey 2021 most often used binaural beats to relax or fall asleep (72 percent), to change their mood (35 percent) or, as underscored, to get a similar effect to that of psychedelic drugs (12 percent).Indeed, such beats are frequently labeled with the drug name for the kind of euphoria they're meant to produce, the survey illustrated. For example, meditation and mindfulness tracks might be named after ingestible drugs such as cannabis and MDMA."Digital drugs, or binaural beats claimed to elicit specific cognitive or emotional states, are a phenomenon about which little is known," the survey's outline says of the study that aimed to "describe demographic and drug use correlates of binaural beat use, patterns of use, reasons for use and methods of access."Lead author Dr. Monica Barratt explained, "Much like ingestible substances, some binaural beats users were chasing a high. But that's far from their only use. Many people saw them as a source of help, such as for sleep therapy or pain relief."She added, however, "It's very new, we just don't know much about the use of binaural beats as digital drugs. This survey shows this is going on in multiple countries. We had anecdotal information, but this was the first time we formally asked people how, why and when they're using them."The results posit the use of binaural beats to experience altered states was reported by five percent of the total sample. In the U.S., 16 percent of respondents said they had tried it. Binaural beat users were overall younger."We're starting to see digital experiences defined as drugs, but they could also be seen as complementary practices alongside drug use," Dr. Barratt said. "Maybe a drug doesn't have to be a substance you consume, it could be to do with how an activity affects your brain."Per the study, the highest rates of reported binaural beat use, in order, was in the U.S., Mexico, Brazil, Poland, Romania and the U.K. See the full results here.In the end, it implies that perhaps we don't know

Digital Drug - Manipulationology [SJSLP-0301] : Digital Drug : Free

If you’re like many modern parents in today’s digital age, then you probably spend a lot of time asking your teen to put away the phone, tablet or laptop. Now it appears that adolescents are using technology — rather than substances — to get high. I-dosing music — and a track called “Gates of Hades” in particular — is the latest risk that threatens the well-being of kids.I-dosing is a type of loud, droning music written in only two tones. The music is “designed to alter the brain waves, just like other drugs can do,” according to Health.More4Kids.com. The combination of tones allegedly brings about “a state of ecstasy.” In some cases, people who listen to “idoser” tracks are also convinced to buy a guide to i-dosing that explains how to get high.Although some feel binaural audio doesn’t influence the brain, others suggest that testing the brain’s response in this way can lead to real substance abuse — and bigger problems. In fact, binaural audio often mimics the same brainwave activity as marijuana, cocaine, LSD and ecstasy.The Negative Effects of I-DosingCracking down on i-dosing may be more difficult than you think. Think of how many hours your teen is online, whether that’s doing homework or posting to Twitter. Limiting screen time helps, as does paying close attention if your teen expresses a constant desire to listen to music. Although Apple Music, Spotify, Pandora and other legitimate music sources are safe, websites such as YouTube may not be.Signs needing further attention include:An obsessive need to listen to music. If your teen starts ignoring other activities and friends in favor of their headphones, i-dosing could be a problem.Odd behavior. If your teen acts as if he is under the influence of drugs or alcohol and you are certain he hasn’t been using, check his devices for digital drugs.Inappropriate laughing, hyperactivity or uncontrollable shaking while listening to music.Trying drugs or alcohol after spending a lot of time using digital drugs.What to Do If Digital Drugs Are a ProblemThere are several steps you can take to avoid problems with i-dosing:Check browser histories and use

Digital Drugs and Are They Dangerous

Parental controls. Maintain a family policy that permits you to spot-check visited websites, especially as they pertain to music.Find out what they’re listening to. If your teen is listening to music intently, ask in a nonthreatening way if you can share.Pay attention to all aspects of their life. Teens who feel isolated or unhappy are more likely to experiment with mind-altering substances and activities. Don’t be discouraged if your first few attempts fail. Keep trying. Be an active listener.Be aware of the signs of alcohol and drug abuse. Slipping grades, new friends, a loss of interest in old activities and sudden changes in mood are all warning signs of drug abuse.Have a discussion. Talk with your teen openly about the risks of using drugs, alcohol and digital drugs, and set clear boundaries.Contact 12 Keys Rehab for More InformationContact us for more information about addiction, or to learn about our holistic treatment program.. Digital Drugs’s tracks 808s by Digital Drugs published on TZ. Lost In by Digital Drugs published on TZ. SUMMER LOVE MIXTAPE by Digital Drugs published on TZ. Moon Visions 2:24 AM Digital drugs use binaural beats to create effects in the brain that are similar to drugs. Find out if digital drugs are safe or a gateway to drugs.

The myth of digital drugs

The tune of USD456 million. The National Medical Device Policy 2023 (“the Policy”) aims to ensure access to patent-centric, innovative and affordable healthcare products of superior quality for better healthcare outcomes. The Policy entails several missions for achieving accelerated growth of the medical devices sector, including:access to and universality of good quality medical devices and healthcare for all ages;affordability and quality of products manufactured in the country to enhance global positioning;acceptability and competitiveness;patient-centric and quality care;ensuring medical devices security through development of strong local manufacturing capabilities and a resilient supply chain for inputs or raw materials; andencouraging innovation and research to enable technology-driven medical devices with IoT, AI, nanotechnology, etc. Further, the Policy also provides a set of strategies covering six areas identified based on the respective challenges and opportunities – namely:regulatory streamlining through, inter alia, the setting up of a Single Window Clearance System for the licensing of medical devices;gradual expansion of the standards developed by the BIS, etc; enabling infrastructure, facilitating R&D and innovation;attracting investments through private route and public procurement policies;brand positioning and awareness creation, so as to manage issues pertaining to market access; and building global competitiveness. The Ministry of Electronics and Information Technology (MeitY) has released a policy paper pertaining to the circular economy in the electronics and electrical sector. The policy paper briefly addresses the role of sustainable product packages and a policy wherein material sourcing can address reducing GHG emissions, footprint and pollution.Additionally, the Ministry of Environment, Forest and Climate Change has introduced target-based extended producer responsibility regimes aimed at – inter alia – setting off e-waste and plastic waste generated by different entities. 5.2 Legislative Reform The MoHFW had proposed a Digital Information Security in Healthcare Act (the “DISHA Act”) for ensuring data privacy and confidentiality, as well as the reliability and security of digital health data. It was later suggested that this be subsumed under a broader national legislation enacted by the MeitY governing the privacy, security and confidentiality of digital information. Further, recognising the fact that the DCA is a pre-independence legislation, the MoHFW proposed the Draft New Drugs, Medical Devices and Cosmetics Bill 2022 (the “Draft NDMDC Bill”). This bill seeks to replace the DCA for regulating drugs, medical devices and cosmetics. The Draft NDMDC Bill seeks to introduce various definitions such as for clinical trial, new drugs and OTC drugs. The bill also seeks to introduce provisions for regulating sale, stocking exhibition, offer for sale, and distribution of drugs through e-pharmacies or any other online mode. As noted in 1.4 Technologies and Digital Health (Medical Apps), the DPDP Act has now become the law. However, the DPDP Act has not yet come into force and will likely have a phased implementation through separate notification(s) issued by the central government. Also, several obligations under the DPDP Act would be operationalised via delegated legislation, which will be introduced in due course. The DPDP Act regulates the “processing” of personal data, which is collected in digital form or in non-digital form

The digital drug - mysticalwonders.org

Secure, automated dispensing cabinet for medications, controlled drugs and narcotics.Your digital "in-house" pharmacy solutionAn automated management system for the administration of controlled substances and narcotics.Includes secured storage cabinet, integrated AI inventory management software and full interface with the patient file.Full and efficient traceability over staff and drugs inventoryAn automated, medication dispensing system for the administration of controlled substances and narcotics. Includes secured drug cabinet, integrated AI inventory management software and full interface with the patient file. The best pharmacy inventory management system to support decentralized dispensing at the point of care. Control of the entire drug issuance process from start to finish, including real-time usage data and expiration dates management The only solution on the market that ensures full adherence to all drug administration regulations. Designed for usage by physicians, anesthetists and nurses within OR and procedure room settings. YOUR POINT OF CARE MEDICATION DISPENSINGSYSTEM – DESIGNED FOR CLINICIANSBenefits for hospitals The secured, automated dispensing system is placed inside core areas, such as operating rooms and procedural rooms Individual drug pull-out and return Full visibility over inventory levels and expiring drugs with real-time alerts Management of drug surplus returns and destruction documentation Simple medication selection and replenishment Strict compliance with drug control regulations Protects against theft and misuse Ability to track ward staff activities and elimination of dispensing mistakes and administration errors Fully integrates with ERP and EHRUSED BY CLINICIANS. MANAGED BY PHARMACISTS Optimizes the pharmaceutical supply chain work in a remote setting Eliminates the need for manual documentation of drug dispensing and returns Dynamic and flexible reporting system that allows the pharmacy to manage and monitor the issuance and administration of narcotic drugs in accordance with the strictest governmental regulatory requirements The automated medication dispensing system issues alert reports and can be viewed at any given moment, portraying in-stock quantities and expiration lists “Exceptions" such as broken ampoules or pull-out of many drugs at once are also documented Control of the entire drug issuance process Placed inside core areas and pharmacies Individual drug pull-out and return Real-time alerts on expiring drugs or stockouts Protects against theft and misuse Ability to track staff activities Full visibility over inventory levels Drug surplus returns and destruction digital documentation Strict compliance with drug control regulations Broken ampoules or pull-out of many drugs at once are documentedNEW!Safe and simple face identificationThe hospital may choose to access the system using face recognition technology, which does not require removing gloves or touching the screen. Alternatively, access to the drug dispenser can be granted through biometric or password identification.Physicians and other medical personnel are recognized with biometric, card or password identification. Left-over items are returned to the cabinet and open dosages are eliminated and reported to the

Digital Drugs : Understanding the Distinction from Chemical Drugs

Is not defined under extant law, as pharmaceuticals are regulated as “drugs” under the DCA read with the Drugs Rules. Drugs as per the DCA include, inter alia:medicines for internal or external use on human beings or animals;substances intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease/disorder in human beings or animals, including preparations for repelling insects;substances intended to affect the structure or any function of the human body; andmedical devices.The DCA read with the Drugs Rules provides the regulatory framework for manufacture, sale, importation and distribution of drugs in India. Blood ProductsThe Drugs Rules define blood products as “a drug manufactured or obtained from pooled plasma of blood by fractionation, drawn from a donor”. These rules further provide guidance on the establishment and operation of blood centres. PsychedelicsPsychedelics are regulated under the Narcotic Drugs and Psychotropic Substances Act 1985 (the “NDPS Act”), which empowers the government to take measures to prevent/combat abuse of narcotic drugs and psychotropic substances (such as cannabis, opium, and heroin) and their trafficking. The use of such substances is permitted under the NDPS Act for scientific or medical purposes. CannabidiolAlthough cannabidiol (CBD) is not specifically covered under prevailing Indian law pertaining to drugs and narcotics, cannabis/hemp is regulated under extant law. Under the NDPS Act, “cannabis” means the separated resin and the flowering or fruiting tops of the cannabis plant (excluding the seeds and leaves when not accompanied by the tops), as well as any mixture – with/without any neutral material – of these forms of cannabis or any drink prepared therefrom. Under the NDPS Act, the cultivation, production, manufacture, possession, sale, purchase, transportation or use of cannabis is punishable with imprisonment and a fine, except when used for medical or scientific purposes. CBD products extracted from hemp are legal in India as long as their THC (tetrahydrocannabinol) content is not higher than 0.3%. Products with higher THC will fall within the category of cannabis and will be covered under the NDPS Act. However, CBD extracted from seeds and leaves of the cannabis plant will likely fall outside the purview of the NDPS Act. Further, under the Food Safety and Standards (Food Products Standards and Food Additives) Regulations 2011 (the “2011 Additives Regulations”), hemp seed (ie, hulled, non-viable seeds obtained from cannabis sativa/other indigenous cannabis species), and hemp seed oil and flour can be sold as food or used as an ingredient in a food for sale subject to conformity with the 2011 Additives Regulations. Under these regulations, the level of CBD – the non-psychoactive component of the cannabis species – in any food for sale consisting of hemp seed or seed products must not exceed 75 mg/kg. 1.4 Technologies and Digital Health Medical AppsCurrently, there are no specific laws governing medical apps in India. However, in 2016 the Department of Health and Family Welfare of the MoHFW issued the Electronic Health Records Standards, which provide the standards for maintenance of electronic health records (pertaining to the identification

People Are Experimenting With 'Digital Drugs'

Are wired for negativity, but in the digital age, it’s time to rewire. Here’s how. Our brains are wired for negativity, but in the digital age, it’s time to rewire. Here’s how. You can't stop negative and mean people from saying hurtful things to your child on social media. But you can use simple, proven techniques using self-talk replacement strategies to guard their hearts. You can't stop negative and mean people from saying hurtful things to your child on social media. But you can use simple, proven techniques using self-talk replacement strategies to guard their hearts. The effects of stress hormones, like cortisol, can make giving up social media use more difficult. The effects of stress hormones, like cortisol, can make giving up social media use more difficult. Recent surveillance indicates apparent renewed interest among teens in Dextromethorphan abuse, sometimes combined with other drugs. Parents and others should be on the alert. Recent surveillance indicates apparent renewed interest among teens in Dextromethorphan abuse, sometimes combined with other drugs. Parents and others should be on the alert.. Digital Drugs’s tracks 808s by Digital Drugs published on TZ. Lost In by Digital Drugs published on TZ. SUMMER LOVE MIXTAPE by Digital Drugs published on TZ. Moon Visions 2:24 AM

Digital Drugs and Binaural Beats

As per a 2022 Parliamentary Standing Committee Report on Medical Devices: Regulation and Control, the expansive definition of medical devices includes digital wearables. While this report does not have the force of the law, it reflects the interpretation of parliament on the subject.Stem CellsStem cell therapy for the treatment of blood cancer and blood disorders (ie, bone marrow transplant or hematopoietic stem cell transplant) are permitted in India. No other form of stem cell therapy is permissible or available in India. The Indian Council of Medical Research (ICMR), jointly with the Department of Biotechnology, issued the National Guidelines for Stem Cell Research 2017 (the “Stem Cell Guidelines”). These guidelines are not applicable to the use of hematopoietic stem cells for treatment of hematological, immunological and metabolic disorders. For hematopoietic stem cell transplantation, the ICMR and the Department of Health Research have issued the National Guidelines for Hematopoietic Cell Transplantation 2021, setting the standards for hematopoietic cell transplantation in India. Further, the government of India enacted the New Drugs and Clinical Trials Rules 2019 for regulation of clinical trials and “new drugs”, which includes within its ambit stem cell-derived products, gene therapeutics products, and xenografts intended to be used as a new drug. 1.5 Borderline Products Although India does not have a separate categorisation of borderline products, regulatory bodies/authorities under extant law have been provided with the power to assess the characteristics of products as drugs, medical devices, and cosmetics and to grant registration accordingly on a case-by-case basis. 2. Commercialisation and Product Life Cycle 2.1 Design and Manufacture Drugs and CosmeticsUnder the DCA, the term “manufacture”, in relation to drugs and cosmetics, includes “any process or part of a process for making, altering, ornamenting, finishing, packing, labelling, breaking up or otherwise treating or adopting any drug or cosmetic with a view to its sale or distribution, but does not include the compounding or dispensing of any drug, or the packing of any drug or cosmetic in the ordinary course of retail business” and “to manufacture shall be construed accordingly”. Additionally, the Drugs Rules provide an inclusive definition of “manufacturer”, which includes “a manufacturer of drugs, who may be a company or a unit or a body corporate or any other establishment in a country other than India, having its drugs manufacturing facilities duly approved by the National Regulatory Authority of that country, and who also has a free sale approval of the drugs approved by said authority in the concerned country, and/or in other major countries”. Generally, drugs are required to comply with the standards laid down in the Second Schedule to the DCA. Depending on the nature of the drugs or cosmetics, the facilities will have different requirements, as noted here.The DCA prohibits a person from manufacturing (for sale or for distribution), selling, stocking, exhibiting, offering for sale, or distributing any drug or cosmetic without obtaining a licence for this in accordance with the provisions of the DCA. Further, the DCA also stipulates the specific requirements for the packaging

The Digital Drug Industry - YouTube

By V.A (Digital Drugs) Streaming + Download Includes unlimited streaming via the free Bandcamp app, plus high-quality download in MP3, FLAC and more. Purchasable with gift card Download available in 16-bit/44.1kHz. €9 Full Digital Discography Purchasable with gift card €302.25 (35% OFF) 1. Sixsense, Hatza Ha Feat. Ambra - New Beginnings 05:15 buy track 2. Infinite Being - Top Of The Mountain 04:46 buy track 3. Enel - Floki 08:46 buy track 4. Chaandanee - Bunker at Night 04:42 buy track 5. Vlad - Kiber Lion 06:35 buy track 6. Nioka - Beautiful Madness 08:31 buy track 7. Foreestal - Mystic Energys 08:13 buy track 8. Hi-Venado - Ufo Dancers 07:09 buy track 9. Ecstatic Earth - Shivas Stash 06:58 buy track 10. Bass Spirit - UFO Landing 07:14 buy track about "Embark on a mesmerizing journey through the ethereal realms of sound with ""Psytrance Shamanic Dreamscape 2024,"" a groundbreaking ten-track compilation meticulously crafted by a league of visionary artists. Presented by the avant-garde record label, Digital Drugs, this compilation transcends the boundaries of ordinary music, catapulting you into a sonic odyssey where the boundaries between reality and imagination blur into a seamless dreamscape. Dive deep into the pulsating beats and intricate rhythms of Psytrance as ""Various Artists"" unveil their sonic wizardry, fusing ancient shamanic vibes with cutting-edge electronic beats. Each track is a portal to a mystical realm, where the hypnotic melodies and rhythmic vibrations awaken the primal forces within. Shamanic Dreamscape 2024"" is not merely a compilation; it's a sonic ritual, an immersive experience that transports you to the very core of your being. Let the psychedelic frequencies guide you through the dance of light and shadow, as the artists weave a tapestry of sonic enchantment." credits released January 5, 2024 licenseall rights reserved tags. Digital Drugs’s tracks 808s by Digital Drugs published on TZ. Lost In by Digital Drugs published on TZ. SUMMER LOVE MIXTAPE by Digital Drugs published on TZ. Moon Visions 2:24 AM

(PDF) digital drugs - Academia.edu

Advancement in digital health tech has created new methods to diagnose and treat patients. It can also provide novel ways to generate and process data, report outcomes and communicate with patients to help better care management. Such digital technology solutions are gaining immense traction in recent times, particularly for remote monitoring of patient symptoms and tele-medicine. Globally, many digital health companies are developing such remote and virtual technologies to bring more affordable and convenient care to more patients.Apricity stands out from the pack in its focus on “helping the doctors help patients”. With its proprietary code-free augmented intelligence (AI) system, the ApricityOncology solution brings clinical best practices developed in hundreds of clinical trials from cancer centers to real world practices. It provides clinical decision support (CDS) based on real-time patient data and up-to-date knowledge to an extended oncology care team, from nurses to doctors, in the clinic or on the cloud, to better manage cancer patients on treatment.An elected member of the National Academy of Medicine, Dr. Chin is renowned for her work in genomics science, studying the Achilles’ heel of cancer to identify the right targets for cancer drug development. She’s been at the forefront of the movement to apply technologies--especially AI (Dr. Chin likes to call it Augmented Intelligence, instead of Artificial), Machine Learning, and big data--to medicine. In addition to Dr. Chin, Apricity’s founding team includes Dr. James Allison, the Nobel-prize winning pioneer of immuno-oncology (IO), in addition to medical oncologists Dr. Padmanee Sharma, scientific director of the Immunotherapy Platform at MD Anderson Cancer Center, and Keith Flaherty, director of Clinical Research at Mass General’s Cancer Center. Throughout their careers, this brain trust of experts in cancer, genomics and immunology have contributed to an acceleration in scientific discovery of the molecular and genetic causes of cancers in ways that have changed cancer diagnoses and treatment. Now they join forces to bring the “ivory tower” care from cancer centers to the real world.Advent and impact of Apricity’s solutionThe market for new cancer drugs has skyrocketed: twice as many IO drugs have entered the development pipeline than there were three years ago, with a total of 4,720 agents in trials in 2020. Apricity’s founders recognized how the complexity and rapid pace of development of new cancer-fighting agents makes it nearly impossible for practicing oncologists and their teams of nurses to optimally incorporate new knowledge in everyday care of their patients on the front line. Optimal benefit from life-saving cancer treatment depends on prompt diagnosis and treatment of side effects so patients can stay on and complete their therapy regimens. However, recognizing the multitude of potential side effect signs and symptoms related to cancer drugs requires substantial clinical experience that